Various techniques for phenolic removal from olive mill wastewater

As the world\u27s population increases, so does the amount of wastewater generated during agricultural activities. Inadequate wastewater management can be the cause of sea and river pollution. However, wastewater can be a potential source of biologically active components that can be obtained via physicochemical, biological, thermochemical or combined treatments. Olive mill wastewater is produced in huge quantities around the world during the production of olive oil. This waste is harmful to the ecological system due to the high content of phenolic components that can be recovered by different methods whereby this waste also gains economic value. This review describes several methods that can be used in phenol removal or isolation from olive mill wastewater

„Mouse fever“ – hemorrhagic fever with renal syndrome – case report

U ovom članku prikazan je slučaj prethodno zdravog 42-godišnjeg drvosječe koji je obolio od hemoragijske vrućice s bubrežnim sindromom (HVBS) ili epidemijske nefropatije. Hemoragijska vrućica s bubrežnim sindromom akutna je infektivna bolest uzrokovana hantavirusima, a glavni rezervoar su glodavci (riđa voluharica i miševi). U Hrvatskoj postoje dva tipa hantavirusa: Puumala i Dobrava-Belgrade. Puumala virus je najčešći oblik hantavirusa u našoj zemlji. Uzročnik je blagog i srednje teškog oblika HVBS. Čovjek se najčešće zarazi udisanjem aerosola koje sadržavaju virus ili drugim kontaminiranim izlučevinama (mokraćom, stolicom, slinom) inficiranih glodavaca. Osnovna značajka HVBS je oštećenje bubrežne funkcije različitog stupnja sve do bubrežnog zatajenja. Česti simptomi su vrućica, glavobolja, bolovi u leđima i bolovi u trbuhu. Dobrava-Belgrade tip virusa uzrokuje težu kliničku sliku s krvarenjima, plućnim i neurološkim simptomima. Tijek HVBS može se podijeliti u pet faza, a to su: febrilna, hipotenzivna, oligurijska, poliurijska i rekonvalescentna faza. Ne postoji specifično liječenje za HVBS, stoga je vrlo važna rana dijagnostika i adekvatno simptomatsko liječenje.PA case of previously healthy 42-year-old woodman who saffered from haemorrhagic fever with renal syndrome (HFRS), also called epidemic nephropathy, is presented. Haemorrhagic fever with renal syndrome belongs to emerging infections. It is caused by hantaviruses. Those viruses are transmitted to humans by rodents, bank vole and mice being the main reservoirs. Two types of hantaviruses are identified in Croatia: Puumala virus and Dobrava-Belgrade virus. Puumala virus is the most frequent hantavirus in our country. It causes mild to moderate form of HFRS. People are infected by inhaling aerosolised virus particles shed through urine, faeces or saliva. The main characteristic of HFRS is renal dysfunction or renal failure with rare haemorrhagic anifestations. Other frequent symptoms are fever, headache, backpain and gastrointestinal symptoms. Dobrava-Belgrade type of virus causes more severe disease with bleedings, pulmonary symptoms and neurological complications. The course of HFRS is divided into five stages: febrile, hypotensive, oliguric, diuretic and convalescent phase, but these phases are not always clinically evident. There is no specific antiviral therapy. Therefore, it is very important that family physicians working in the regions where HFRS usually occures, have it in mind in cases of patients with sudden onset of fever or flu-like symptom

FROM MODEL TO WARNING: Narratives of Resettlement “Home to the Reich” after World War II

Fisher G. FROM MODEL TO WARNING: Narratives of Resettlement “Home to the Reich” after World War II. In: Molnar C, Zakic M, eds. German-Balkan Entangled Histories in the Twentieth Century. Pittsburgh University Press; 2020: 180-201

Food industry by-products : knjiga sažetaka : 3. međunarodni znanstveno-stručni skup FOOD INDUSTRY BY-PRODUCTS

Book of Abstracts includes abstratcs of plenary, invited lectures and poster presentations held at the 4th International Scientific and Professional Conference FOOD INDUSTRY BY-PRODUCTS, related to the issue of disposal and potential use of various by-products of the food industry. The holding of the Conference and the publication of the Book of Abstracts were co-financed by the Croatian Science Foundation with the project "The possibility of exploiting traditional apple cultivars for the production of apples and apple juice with the reduced patulin content"

Rivaroxaban with or without aspirin in stable cardiovascular disease

BACKGROUND: We evaluated whether rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone for secondary cardiovascular prevention. METHODS: In this double-blind trial, we randomly assigned 27,395 participants with stable atherosclerotic vascular disease to receive rivaroxaban (2.5 mg twice daily) plus aspirin (100 mg once daily), rivaroxaban (5 mg twice daily), or aspirin (100 mg once daily). The primary outcome was a composite of cardiovascular death, stroke, or myocardial infarction. The study was stopped for superiority of the rivaroxaban-plus-aspirin group after a mean follow-up of 23 months. RESULTS: The primary outcome occurred in fewer patients in the rivaroxaban-plus-aspirin group than in the aspirin-alone group (379 patients [4.1%] vs. 496 patients [5.4%]; hazard ratio, 0.76; 95% confidence interval [CI], 0.66 to 0.86; P<0.001; z=−4.126), but major bleeding events occurred in more patients in the rivaroxaban-plus-aspirin group (288 patients [3.1%] vs. 170 patients [1.9%]; hazard ratio, 1.70; 95% CI, 1.40 to 2.05; P<0.001). There was no significant difference in intracranial or fatal bleeding between these two groups. There were 313 deaths (3.4%) in the rivaroxaban-plus-aspirin group as compared with 378 (4.1%) in the aspirin-alone group (hazard ratio, 0.82; 95% CI, 0.71 to 0.96; P=0.01; threshold P value for significance, 0.0025). The primary outcome did not occur in significantly fewer patients in the rivaroxaban-alone group than in the aspirin-alone group, but major bleeding events occurred in more patients in the rivaroxaban-alone group. CONCLUSIONS: Among patients with stable atherosclerotic vascular disease, those assigned to rivaroxaban (2.5 mg twice daily) plus aspirin had better cardiovascular outcomes and more major bleeding events than those assigned to aspirin alone. Rivaroxaban (5 mg twice daily) alone did not result in better cardiovascular outcomes than aspirin alone and resulted in more major bleeding events